Skip to Main Navigation
Skip to Page Content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
https://ntp.niehs.nih.gov/go/1547

TDMS Study 05162-10 Pathology Tables

NTP Experiment-Test: 05162-10         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                           DIETHANOLAMINE                                      Date: 06/11/96
Route: SKIN APPLICATION                                                                                           Time: 11:08:11

                                                           CORE STUDY




       Facility:  Battelle Columbus Laboratory

       Chemical CAS #:  111-42-2

       Lock Date:  06/04/93

       Cage Range:  All

       Reasons For Removal:    All

       Removal Date Range:     All

       Treatment Groups:       Include All


































a  Number of animals examined microscopically at site and number of animals with lesion

                                                              Page   1

NTP Experiment-Test: 05162-10         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                           DIETHANOLAMINE                                      Date: 06/11/96  
Route: SKIN APPLICATION                                                                                           Time: 11:08:11  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE FEMALE                        0 MG/KG      40 MG/KG     80 MG/KG     160                                       
                                                                                          MG/KG                                     
____________________________________________________________________________________________________________________________________
DISPOSITION SUMMARY                                                                                                                 
  Animals Initially In Study                          50           50           50           50                                     
  Early Deaths                                                                                                                      
    Natural Death                                      2            9            8           14                                     
    Moribund Sacrifice                                 4            8            9           13                                     
  Survivors                                                                                                                         
    Terminal Sacrifice                                44           33           33           22                                     
    Natural Death                                                                             1                                     
  Animals Examined Microscopically                    50           50           50           50                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Intestine Small, Jejunum                           (50)         (50)         (50)         (49)                                   
      Peyer's Patch, Hyperplasia, Lymphoid             1 (2%)                                                                       
   Liver                                              (50)         (50)         (50)         (50)                                   
      Clear Cell Focus                                              2 (4%)                                                          
      Eosinophilic Focus                               3 (6%)       4 (8%)                                                          
      Necrosis                                         1 (2%)       1 (2%)       1 (2%)                                             
      Syncytial Alteration                                          2 (4%)      17 (34%)     18 (36%)                               
      Hepatocyte, Vacuolization Cytoplasmic            1 (2%)                                                                       
      Periportal, Kupffer Cell, Amyloid Deposition     1 (2%)                                                                       
   Mesentery                                          (4)          (5)          (1)          (2)                                    
      Fat, Inflammation, Chronic                       3 (75%)      4 (80%)                   1 (50%)                               
   Pancreas                                           (50)         (50)         (50)         (49)                                   
      Inflammation, Granulomatous                      1 (2%)                                                                       
      Acinus, Atrophy                                               2 (4%)                                                          
      Acinus, Cytoplasmic Alteration, Focal            1 (2%)                                                                       
   Salivary Glands                                    (50)         (50)         (50)         (50)                                   
      Infiltration Cellular, Lymphocyte                                                       1 (2%)                                
      Duct, Cytoplasmic Alteration                     1 (2%)                                                                       
   Stomach, Forestomach                               (50)         (50)         (50)         (49)                                   
      Hyperplasia, Focal, Squamous                     1 (2%)       6 (12%)      5 (10%)                                            
      Mineralization, Diffuse                                       1 (2%)                                                          
   Stomach, Glandular                                 (50)         (50)         (50)         (49)                                   
      Necrosis, Focal                                                                         3 (6%)                                
   Tooth                                              (1)                                                                           
      Developmental Malformation                       1 (100%)                                                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Heart                                              (50)         (50)         (50)         (50)                                   
      Atrium, Thrombosis                                                         1 (2%)       4 (8%)                                
      Myocardium, Degeneration, Acute                               1 (2%)                                                          
____________________________________________________________________________________________________________________________________
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    2                                                              
NTP Experiment-Test: 05162-10         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                           DIETHANOLAMINE                                      Date: 06/11/96  
Route: SKIN APPLICATION                                                                                           Time: 11:08:11  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE FEMALE                        0 MG/KG      40 MG/KG     80 MG/KG     160                                       
                                                                                          MG/KG                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Cortex                                     (50)         (50)         (50)         (50)                                   
      Accessory Adrenal Cortical Nodule                1 (2%)                                                                       
      Amyloid Deposition                               1 (2%)                                                                       
      Angiectasis                                      1 (2%)       1 (2%)       1 (2%)                                             
      Degeneration, Diffuse                                                                   1 (2%)                                
      Hemorrhage                                                                 1 (2%)       4 (8%)                                
      Hypertrophy, Diffuse                             1 (2%)                                                                       
      Hypertrophy, Focal                                                                      1 (2%)                                
      Necrosis                                                      1 (2%)                                                          
      Vacuolization Cytoplasmic, Focal                 1 (2%)                                                                       
      Zona Reticularis, Pigmentation                   1 (2%)                                                                       
   Islets, Pancreatic                                 (50)         (50)         (50)         (49)                                   
      Hyperplasia, Focal                                            2 (4%)       1 (2%)       2 (4%)                                
   Pituitary Gland                                    (50)         (50)         (47)         (44)                                   
      Pars Distalis, Cyst                              1 (2%)       1 (2%)       2 (4%)                                             
      Pars Distalis, Hemorrhage, Focal                              1 (2%)                                                          
      Pars Distalis, Hyperplasia                       4 (8%)       4 (8%)       3 (6%)       1 (2%)                                
      Pars Intermedia, Hyperplasia                     1 (2%)                                                                       
   Thyroid Gland                                      (50)         (50)         (50)         (49)                                   
      Follicle, Cyst                                                             1 (2%)       1 (2%)                                
      Follicular Cell, Hyperplasia                    18 (36%)     28 (56%)     32 (64%)     39 (80%)                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Clitoral Gland                                     (46)         (48)         (46)         (43)                                   
      Cyst                                                          1 (2%)                                                          
   Ovary                                              (49)         (50)         (49)         (49)                                   
      Atrophy                                         42 (86%)     35 (70%)     44 (90%)     49 (100%)                              
      Thrombosis                                       1 (2%)                    1 (2%)       1 (2%)                                
      Follicle, Cyst                                  10 (20%)     18 (36%)     12 (24%)     10 (20%)                               
      Periovarian Tissue, Cyst                                      1 (2%)       1 (2%)       1 (2%)                                
      Periovarian Tissue, Inflammation,                                                                                             
          Granulomatous                                1 (2%)                                                                       
   Uterus                                             (50)         (50)         (50)         (50)                                   
      Angiectasis                                      1 (2%)                                                                       
      Congestion                                                                 1 (2%)                                             
      Hyperplasia                                      1 (2%)                                                                       
      Infiltration Cellular, Lymphocyte                                          1 (2%)                                             
      Thrombosis                                                                              1 (2%)                                
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    3                                                              
NTP Experiment-Test: 05162-10         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                           DIETHANOLAMINE                                      Date: 06/11/96  
Route: SKIN APPLICATION                                                                                           Time: 11:08:11  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE FEMALE                        0 MG/KG      40 MG/KG     80 MG/KG     160                                       
                                                                                          MG/KG                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
GENITAL SYSTEM - CONT                                                                                                               
      Endometrium, Hyperplasia, Cystic                45 (90%)     44 (88%)     31 (62%)     25 (50%)                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Bone Marrow                                        (50)         (50)         (50)         (50)                                   
      Myelofibrosis                                   14 (28%)     19 (38%)     11 (22%)      8 (16%)                               
      Myeloid Cell, Hyperplasia                        1 (2%)       1 (2%)       1 (2%)                                             
   Lymph Node                                         (9)          (2)          (5)                                                 
      Lumbar, Infiltration Cellular, Plasma Cell       1 (11%)                                                                      
      Mediastinal, Hyperplasia, Lymphoid               1 (11%)                                                                      
      Pancreatic, Inflammation, Granulomatous          1 (11%)                                                                      
   Lymph Node, Mandibular                             (46)         (48)         (46)         (43)                                   
      Hyperplasia, Lymphoid                                         1 (2%)                                                          
      Infiltration Cellular, Plasma Cell                                                      1 (2%)                                
      Necrosis                                         1 (2%)                                 3 (7%)                                
   Lymph Node, Mesenteric                             (48)         (48)         (44)         (40)                                   
      Congestion                                                                 1 (2%)                                             
      Necrosis                                         2 (4%)       3 (6%)       2 (5%)       7 (18%)                               
   Spleen                                             (50)         (50)         (50)         (50)                                   
      Hematopoietic Cell Proliferation                24 (48%)     31 (62%)     41 (82%)     43 (86%)                               
      Hyperplasia, Lymphoid                                         2 (4%)                    1 (2%)                                
      Pigmentation, Diffuse, Hemosiderin               1 (2%)                                                                       
      Pigmentation, Hemosiderin                                                               1 (2%)                                
      Lymphoid Follicle, Depletion Cellular                         1 (2%)                                                          
   Thymus                                             (48)         (42)         (41)         (36)                                   
      Atrophy                                          3 (6%)       6 (14%)      8 (20%)     21 (58%)                               
      Hyperplasia, Lymphoid                            1 (2%)                                                                       
      Necrosis                                                      6 (14%)      3 (7%)       4 (11%)                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Mammary Gland                                      (49)         (47)         (47)         (40)                                   
      Hyperplasia                                      1 (2%)                    2 (4%)                                             
   Skin                                               (50)         (50)         (50)         (50)                                   
      Skin, Site of Application, Acanthosis                         2 (4%)       1 (2%)       2 (4%)                                
      Skin, Site of Application, Exudate                            1 (2%)       1 (2%)       3 (6%)                                
      Skin, Site of Application, Hyperkeratosis        1 (2%)       3 (6%)       8 (16%)     16 (32%)                               
      Skin, Site of Application, Ulcer                              1 (2%)                                                          
      Subcutaneous Tissue, Edema, Diffuse                           1 (2%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    4                                                              
NTP Experiment-Test: 05162-10         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                           DIETHANOLAMINE                                      Date: 06/11/96  
Route: SKIN APPLICATION                                                                                           Time: 11:08:11  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE FEMALE                        0 MG/KG      40 MG/KG     80 MG/KG     160                                       
                                                                                          MG/KG                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   Skeletal Muscle                                    (1)          (1)                                                              
      Inflammation, Granulomatous                      1 (100%)                                                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (50)         (50)         (50)         (50)                                   
      Hydrocephalus                                    1 (2%)                                                                       
      Cerebrum, Cyst Epithelial Inclusion              1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Lung                                               (50)         (50)         (50)         (50)                                   
      Inflammation, Chronic                                                      1 (2%)       1 (2%)                                
      Inflammation, Chronic Active                                               1 (2%)                                             
      Alveolar Epithelium, Hyperplasia                 1 (2%)                    2 (4%)       1 (2%)                                
      Alveolus, Infiltration Cellular, Histiocyte                                2 (4%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   Eye                                                                          (1)          (2)                                    
      Degeneration                                                                            2 (100%)                              
      Cornea, Inflammation, Chronic Active                                       1 (100%)                                           
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (50)         (50)         (50)         (50)                                   
      Metaplasia, Focal, Osseous                       2 (4%)                                                                       
      Nephropathy                                     25 (50%)     24 (48%)     16 (32%)     17 (34%)                               
      Cortex, Cyst                                     1 (2%)                    1 (2%)                                             
      Cortex, Infarct                                  1 (2%)                                 2 (4%)                                
      Glomerulus, Amyloid Deposition                   1 (2%)                                                                       
      Renal Tubule, Dilatation                                                   1 (2%)                                             
      Renal Tubule, Mineralization                                  4 (8%)       3 (6%)                                             
      Renal Tubule, Pigmentation                                    1 (2%)                                                          
   Urinary Bladder                                    (50)         (49)         (50)         (48)                                   
      Infiltration Cellular, Lymphocyte                                          1 (2%)                                             
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    5                                                              
NTP Experiment-Test: 05162-10         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                           DIETHANOLAMINE                                      Date: 06/11/96  
Route: SKIN APPLICATION                                                                                           Time: 11:08:11  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE MALE                          0 MG/KG      40 MG/KG     80 MG/KG     160                                       
                                                                                          MG/KG                                     
____________________________________________________________________________________________________________________________________
DISPOSITION SUMMARY                                                                                                                 
  Animals Initially In Study                          50           50           50           50                                     
  Early Deaths                                                                                                                      
    Natural Death                                      7            6           10            9                                     
    Moribund Sacrifice                                 3            1            6           10                                     
    Accidently Killed                                                                         1                                     
  Survivors                                                                                                                         
    Terminal Sacrifice                                40           41           34           30                                     
    Natural Death                                                   2                                                               
  Animals Examined Microscopically                    50           50           50           50                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Intestine Large, Cecum                             (50)         (49)         (50)         (50)                                   
      Lymphoid Tissue, Hyperplasia, Lymphoid                        1 (2%)                                                          
      Lymphoid Tissue, Inflammation, Chronic Active                              1 (2%)                                             
   Intestine Small, Duodenum                          (50)         (49)         (49)         (50)                                   
      Peyer's Patch, Hyperplasia, Lymphoid                                       1 (2%)                                             
   Liver                                              (50)         (50)         (50)         (50)                                   
      Basophilic Focus                                 2 (4%)       1 (2%)                                                          
      Clear Cell Focus                                 4 (8%)       7 (14%)      2 (4%)       2 (4%)                                
      Clear Cell Focus, Multiple                       1 (2%)                                                                       
      Eosinophilic Focus                               3 (6%)       4 (8%)       2 (4%)       4 (8%)                                
      Eosinophilic Focus, Multiple                                                            1 (2%)                                
      Hematopoietic Cell Proliferation                                                        1 (2%)                                
      Hematopoietic Cell Proliferation, Diffuse                     1 (2%)                                                          
      Hepatodiaphragmatic Nodule                       1 (2%)       1 (2%)                                                          
      Inflammation, Suppurative                                                  1 (2%)                                             
      Necrosis                                         2 (4%)                                                                       
      Syncytial Alteration                                         28 (56%)     38 (76%)     23 (46%)                               
      Thrombosis                                                    1 (2%)       1 (2%)                                             
      Centrilobular, Cytoplasmic Alteration            1 (2%)      17 (34%)     17 (34%)     12 (24%)                               
   Mesentery                                          (1)                                                                           
      Fat, Inflammation, Chronic                       1 (100%)                                                                     
   Pancreas                                           (50)         (50)         (50)         (50)                                   
      Inflammation, Chronic Active                     1 (2%)                                                                       
      Acinus, Atrophy                                  2 (4%)       2 (4%)                    1 (2%)                                
      Acinus, Cytoplasmic Alteration                   1 (2%)                    1 (2%)       3 (6%)                                
   Salivary Glands                                    (50)         (50)         (50)         (50)                                   
      Duct, Cytoplasmic Alteration                     1 (2%)       2 (4%)       8 (16%)     23 (46%)                               
   Stomach, Forestomach                               (50)         (49)         (50)         (50)                                   
      Hyperplasia, Focal, Squamous                     1 (2%)       4 (8%)       4 (8%)       2 (4%)                                
   Stomach, Glandular                                 (50)         (49)         (50)         (50)                                   
      Necrosis                                                      1 (2%)       1 (2%)                                             
      Pigmentation                                                               3 (6%)                                             
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    6                                                              
NTP Experiment-Test: 05162-10         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                           DIETHANOLAMINE                                      Date: 06/11/96  
Route: SKIN APPLICATION                                                                                           Time: 11:08:11  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE MALE                          0 MG/KG      40 MG/KG     80 MG/KG     160                                       
                                                                                          MG/KG                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
      Epithelium, Hyperplasia, Focal                                1 (2%)                    2 (4%)                                
   Tooth                                              (3)          (2)                                                              
      Developmental Malformation                       1 (33%)      2 (100%)                                                        
      Peridontal Tissue, Inflammation, Chronic                                                                                      
          Active                                       2 (67%)                                                                      
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Blood Vessel                                       (50)         (50)         (50)         (49)                                   
      Adventitia, Inflammation, Chronic                                                       1 (2%)                                
   Heart                                              (50)         (50)         (50)         (50)                                   
      Atrium, Thrombosis                                                                      6 (12%)                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Cortex                                     (50)         (50)         (50)         (50)                                   
      Hyperplasia, Focal                                                         1 (2%)       3 (6%)                                
      Hypertrophy, Diffuse                             1 (2%)                                                                       
      Hypertrophy, Focal                               6 (12%)      8 (16%)      4 (8%)       7 (14%)                               
      Vacuolization Cytoplasmic, Focal                                           1 (2%)                                             
      Capsule, Hyperplasia                             2 (4%)       6 (12%)      5 (10%)      3 (6%)                                
   Islets, Pancreatic                                 (50)         (50)         (50)         (50)                                   
      Hyperplasia                                      2 (4%)                                                                       
   Parathyroid Gland                                  (41)         (41)         (41)         (43)                                   
      Cyst                                                          1 (2%)                                                          
   Pituitary Gland                                    (48)         (47)         (46)         (43)                                   
      Craniopharyngeal Duct, Pars Distalis, Cyst       1 (2%)                                                                       
      Pars Distalis, Cyst                              2 (4%)       1 (2%)       1 (2%)       3 (7%)                                
      Pars Distalis, Hyperplasia                       2 (4%)                                                                       
   Thyroid Gland                                      (50)         (49)         (50)         (50)                                   
      Follicular Cell, Hyperplasia                    18 (36%)     22 (45%)     30 (60%)     42 (84%)                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   Tissue NOS                                                                                (1)                                    
      Pelvic, Abscess                                                                         1 (100%)                              
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Epididymis                                         (50)         (50)         (50)         (50)                                   
      Granuloma Sperm                                                                         1 (2%)                                
   Preputial Gland                                    (50)         (50)         (50)         (49)                                   
      Cyst                                            16 (32%)     12 (24%)     20 (40%)     12 (24%)                               
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    7                                                              
NTP Experiment-Test: 05162-10         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                           DIETHANOLAMINE                                      Date: 06/11/96  
Route: SKIN APPLICATION                                                                                           Time: 11:08:11  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE MALE                          0 MG/KG      40 MG/KG     80 MG/KG     160                                       
                                                                                          MG/KG                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
GENITAL SYSTEM - CONT                                                                                                               
      Inflammation, Chronic Active                     3 (6%)       5 (10%)      1 (2%)       3 (6%)                                
   Prostate                                           (50)         (50)         (50)         (50)                                   
      Inflammation, Chronic Active                                                            1 (2%)                                
      Inflammation, Diffuse, Suppurative                            1 (2%)                                                          
   Seminal Vesicle                                    (50)         (50)         (50)         (50)                                   
      Inflammation, Diffuse, Suppurative                            1 (2%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Bone Marrow                                        (50)         (50)         (50)         (50)                                   
      Myeloid Cell, Depletion Cellular                                           1 (2%)                                             
   Lymph Node                                         (1)          (2)          (1)                                                 
      Hyperplasia, Lymphoid                                         1 (50%)                                                         
   Lymph Node, Mandibular                             (46)         (46)         (44)         (36)                                   
      Necrosis                                                      3 (7%)       2 (5%)       2 (6%)                                
   Lymph Node, Mesenteric                             (45)         (43)         (41)         (41)                                   
      Angiectasis                                      1 (2%)                                                                       
      Congestion                                       2 (4%)                    1 (2%)                                             
      Inflammation, Suppurative                                                  1 (2%)                                             
      Necrosis                                                      4 (9%)       1 (2%)       6 (15%)                               
   Spleen                                             (50)         (50)         (50)         (50)                                   
      Hematopoietic Cell Proliferation                13 (26%)     22 (44%)     29 (58%)     32 (64%)                               
      Hyperplasia, Lymphoid                                         1 (2%)                                                          
      Thrombosis                                                    1 (2%)                                                          
      Lymphoid Follicle, Necrosis                      1 (2%)                                                                       
      Red Pulp, Depletion Cellular                     1 (2%)                                                                       
   Thymus                                             (37)         (42)         (39)         (36)                                   
      Atrophy                                          8 (22%)      8 (19%)     18 (46%)     17 (47%)                               
      Cyst                                                          1 (2%)                                                          
      Necrosis                                         2 (5%)       1 (2%)       3 (8%)       2 (6%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Skin                                               (50)         (50)         (50)         (50)                                   
      Hyperkeratosis                                                                          1 (2%)                                
      Dermis, Fibrosis                                                                        1 (2%)                                
      Skin, Site of Application, Acanthosis                                      2 (4%)       4 (8%)                                
      Skin, Site of Application, Exudate                                                      3 (6%)                                
      Skin, Site of Application, Hyperkeratosis                    13 (26%)     10 (20%)     17 (34%)                               
      Skin, Site of Application, Inflammation,                                                                                      
           Chronic                                                                            1 (2%)                                
      Skin, Site of Application, Ulcer                 1 (2%)                    1 (2%)                                             
      Subcutaneous Tissue, Angiectasis                 1 (2%)                                                                       
      Subcutaneous Tissue, Edema                                                              1 (2%)                                
      Subcutaneous Tissue, Fibrosis                                              1 (2%)                                             
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    8                                                              
NTP Experiment-Test: 05162-10         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                           DIETHANOLAMINE                                      Date: 06/11/96  
Route: SKIN APPLICATION                                                                                           Time: 11:08:11  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE MALE                          0 MG/KG      40 MG/KG     80 MG/KG     160                                       
                                                                                          MG/KG                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   Bone                                               (50)         (50)         (50)         (50)                                   
      Hyperostosis                                                  1 (2%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (50)         (50)         (50)         (50)                                   
      Hemorrhage                                                                              1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Lung                                               (50)         (50)         (50)         (50)                                   
      Inflammation, Diffuse, Granulomatous                                       1 (2%)                                             
      Inflammation, Suppurative                                                  1 (2%)                                             
      Alveolar Epithelium, Hyperplasia                 2 (4%)       2 (4%)       2 (4%)       1 (2%)                                
      Alveolus, Infiltration Cellular, Histiocyte                                             1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (50)         (50)         (50)         (50)                                   
      Hydronephrosis                                   1 (2%)                                                                       
      Infiltration Cellular, Lymphocyte                2 (4%)                    1 (2%)                                             
      Inflammation, Chronic, Diffuse                                             1 (2%)                                             
      Nephropathy                                     45 (90%)     47 (94%)     45 (90%)     48 (96%)                               
      Cortex, Cyst                                                  5 (10%)      2 (4%)                                             
      Cortex, Infarct                                               1 (2%)                                                          
      Glomerulus, Dilatation, Diffuse                  1 (2%)                    1 (2%)       1 (2%)                                
      Glomerulus, Dilatation, Focal                   22 (44%)     39 (78%)     39 (78%)     32 (64%)                               
      Pelvis, Inflammation, Suppurative                             1 (2%)                                                          
      Renal Tubule, Dilatation                                      1 (2%)                                                          
      Renal Tubule, Hyperplasia, Focal                 1 (2%)       2 (4%)                    3 (6%)                                
      Renal Tubule, Mineralization                    38 (76%)     45 (90%)     38 (76%)     41 (82%)                               
      Renal Tubule, Pigmentation, Hemosiderin                       1 (2%)       2 (4%)       1 (2%)                                
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    9                                                              
NTP Experiment-Test: 05162-10         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                           DIETHANOLAMINE                                      Date: 06/11/96  
Route: SKIN APPLICATION                                                                                           Time: 11:08:11  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE MALE                          0 MG/KG      40 MG/KG     80 MG/KG     160                                       
                                                                                          MG/KG                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
URINARY SYSTEM - CONT                                                                                                               
      Renal Tubule, Vacuolization Cytoplasmic                                                 1 (2%)                                
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   10                                                              
                             ------------------------------------------------------------                                           
                             ----------              END OF REPORT             ----------                                           
                             ------------------------------------------------------------